NCT05669534View on ClinicalTrials.gov

Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP

PHASE4RecruitingINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

January 31, 2027

Study Completion Date

January 1, 2027

Conditions
HivOpioid Use Disorder
Interventions
BEHAVIORAL

community-friendly health recovery program

Participants will receive 4 weekly 45 minute sessions HIV prevention sessions.

DRUG

Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis

Participants will be prescribed Pre-exposure prophylaxis (PrEP) is a biomedical intervention.

Trial Locations (1)

06519

RECRUITING

APT Foundation, New Haven

All Listed Sponsors
lead

University of Connecticut

OTHER